Page 8 - Five Prime News Today : Breaking News, Live Updates & Top Stories | Vimarsana

<div class="at-above-post addthis_tool" data-url="https://www.metro.us/amgen-bets-on-1-9-billion/"></div>(Reuters) – Drugmaker Amgen Inc is buying Five Prime Therapeutics for about $1.9 billion to expand its line of gastric cancer drug candidates and its presence in Asia-Pacific, the companies said on Thursday. Amgen has been looking to grow in the oncology market in the region since gaining a toehold in China in 2019 through […]<!-- AddThis Advanced Settings above via filter on get_the_excerpt --><!-- AddThis Advanced Settings below via fi...

Amgen has its own experimental gastric cancer drugs it hopes it might be able to combine with Five Prime's bemarituzumab.

Amgen Inc (NASDAQ: AMGN) has agreed to acquire Five Prime Therapeutics Inc (NASDAQ: FPRX) for $38 per share in cash, ...

/PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Five Prime...

WILMINGTON, Del., March 04, 2021 -- Rigrodsky Law, P.A. announces that it is investigating Five Prime Therapeutics, Inc. regarding possible breaches of fiduciary duties and other...